Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 23, 2026 17:25 ET | Source: Immunovant Inc. DURHAM, N.C. and…
Intuitive Announces Fourth Quarter Earnings
SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq:…
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22,…
Parker to Announce Fiscal 2026 Second Quarter Earnings on January 29; Conference Call and Webcast Scheduled for 11 a.m. Eastern
CLEVELAND, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH),…
Bank of America Reports Fourth Quarter 2025 Financial Results
CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- Bank of America reported its…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
January 13, 2026 07:05 ET | Source: Treace Medical Concepts, Inc. PONTE…
Varonis Announces Date of Fourth Quarter and Full-Year 2025 Financial Results
January 09, 2026 16:05 ET | Source: Varonis Systems, Inc. MIAMI, Jan.…
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
January 02, 2026 16:05 ET | Source: Regeneron Pharmaceuticals, Inc. TARRYTOWN, N.Y.,…
BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership
IRVING, Texas, Dec. 31, 2025 (GLOBE NEWSWIRE) -- As 2025 ends, BioNTX…
